
FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
FDA News Release Nalmefene Hydrochloride Product in Nasal Spray Form Provides Additional Tool for Harm Reduction Groups and First Responders For Immediate Release: May 22, 2023 Today, the U.S. Food and Drug Administration approved Opvee, the first …